Literature DB >> 6491379

Production of experimental endocarditis by coagulase-negative staphylococci: variability in species virulence.

L M Baddour, G D Christensen, M G Hester, A L Bisno.   

Abstract

The abilities of 11 coagulase-negative staphylococcal isolates of human origin to establish infective endocarditis in a rat model were compared. Seven of the strains were Staphylococcus epidermidis, the species most commonly causing endocarditis in humans. The other four strains were Staphylococcus hominis, an infrequent cause of endocarditis. Four of the seven strains of S. epidermidis and two of the four strains of S. hominis elaborated surface slime. With an inoculum of 10(7) colony-forming units, endocarditis was established in all of 77 rats injected with S. epidermidis but in only five (12.5%) of 40 animals injected with S. hominis (P less than .001). Strains of S. epidermidis were significantly more resistant to phagocytic killing in vitro than were strains of S. hominis. These data indicate that there are major differences in the virulence of various species of coagulase-negative staphylococci, both in vivo and in vitro, and that these differences are reflected in the observed incidence of disease caused in humans by the respective species.

Entities:  

Mesh:

Year:  1984        PMID: 6491379     DOI: 10.1093/infdis/150.5.721

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  30 in total

1.  Defensins impair phagocytic killing by neutrophils in biomaterial-related infection.

Authors:  S S Kaplan; R P Heine; R L Simmons
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

2.  Role of adherence in infective endocarditis.

Authors:  M A Kielhofner; R J Hamill
Journal:  Tex Heart Inst J       Date:  1989

3.  Adherence measured by microtiter assay as a virulence marker for Staphylococcus epidermidis infections.

Authors:  M A Deighton; B Balkau
Journal:  J Clin Microbiol       Date:  1990-11       Impact factor: 5.948

4.  Protective efficacy of antibodies to the Staphylococcus aureus type 5 capsular polysaccharide in a modified model of endocarditis in rats.

Authors:  J C Lee; J S Park; S E Shepherd; V Carey; A Fattom
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

5.  Strong slime production is a marker of clinical significance in Staphylococcus epidermidis isolated from intravascular catheters.

Authors:  M Mateo; J R Maestre; L Aguilar; M J Giménez; J J Granizo; J Prieto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-12-18       Impact factor: 3.267

6.  Pathogenicity and virulence of coagulase negative staphylococci in relation to adherence, hydrophobicity, and toxin production in vitro.

Authors:  C Molnàr; Z Hevessy; F Rozgonyi; C G Gemmell
Journal:  J Clin Pathol       Date:  1994-08       Impact factor: 3.411

7.  Staphylococcal exopolysaccharides inhibit lymphocyte proliferative responses by activation of monocyte prostaglandin production.

Authors:  R D Stout; K P Ferguson; Y N Li; D W Lambe
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

8.  Ultrasonically enhanced vancomycin activity against Staphylococcus epidermidis biofilms in vivo.

Authors:  J C Carmen; B L Roeder; J L Nelson; B L Beckstead; C M Runyan; G B Schaalje; R A Robison; W G Pitt
Journal:  J Biomater Appl       Date:  2004-04       Impact factor: 2.646

Review 9.  Current problems of chemotherapy of infections with coagulase-negative staphylococci.

Authors:  A J Davies; J W Stone
Journal:  Eur J Clin Microbiol       Date:  1986-06       Impact factor: 3.267

10.  Adherence of Staphylococcus epidermidis to fibrin-platelet clots in vitro mediated by lipoteichoic acid.

Authors:  T D Chugh; G J Burns; H J Shuhaiber; G M Bahr
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.